The occurrence and general applicability of the CD4:8 ratio as a surrogate predictor of mortality among the oldest old have only been tested in a few longitudinal studies. Here, the predictive value of CD4:8 ratio for mortality with respect to the role of cytomegalovirus (CMV) infection was investigated. Using polychromatic flow cytometry, the CD4:8 ratio and T-cell subsets of 235 individuals aged 81.5 years or older were analyzed, and mortality data were collected after a mean period of 3.3 years. The hazard for all-cause mortality adjusted for age, comorbidity, and CMV serostatus increased 1.53-fold (95% CI: 0.94-2.51) with every increment in the CD4:8 ratio from R < 1, to 1 < R < 5 and R > 5 among women. A negative hazard ratio of 0.50 for CMV seropositivity in women indicated an apparently protective effect of this virus. In men, no associations with survival were observed. No mediation effect could be found for the CD4:8 ratio with respect to the relationship between CMV serostatus and mortality. Very elderly CMV-negative women with a R > 5 experienced the highest mortality rates, independent of age and comorbidity. The associations of CMV serostatus and CD4:8 ratio with mortality seem to reflect distinct pathways mediating life span in very old humans.
Human life expectancy has doubled over the last century, and the proportion of individuals attaining a very high age of 80 years or more is increasing worldwide. Mortality due to infectious disease continues to accelerate in late life, unlike cancer and cardiovascular mortality (1) . This is believed to be the result of a decreased ability of the immune system to counteract new antigenic challenges and to maintain memory and/or immunosurveillance against earlier exposures (2) . Changes to innate and adaptive immunity, both in composition and function, occur during the lifetime of an individual. Especially changes in the T-cell compartment characterize the phenomenon of immunosenescence (ie, the consequences of immune system aging). These changes include the accumulation of late-differentiated effector/memory T cells and a reduced number of naïve T cells, in both cases with CD8 + T cells manifesting greater differences than CD4 + T cells. Accompanying sex-specific health disparities, differences in survival rates and immune responses and age-associated immune changes between men and women have been described (3) (4) (5) . However, the influence of gender on immune responses is not often taken into consideration in studies of immune competence in the elderly people, but should be included in such analyses. Likewise, the presence of cytomegalovirus (CMV, the common persistent β-herpes virus HHV5) plays a key role in the changes in immune signatures associated with immunosenescence, but has often also been ignored in such studies (2, 5) .
The longitudinal Swedish OCTO and NONA studies of free-living individuals older than 85 years at baseline identified an "immune risk profile" (IRP) in 15% of the study population. These individuals were characterized by having an inverted CD4:8 ratio (R < 1), increased absolute numbers of CD8 + CD28 − T cells in the blood, poor mitogen-induced T-cell proliferative responses, low frequencies of B cells, and seropositivity for CMV (6) (7) (8) (9) . This IRP was weakly associated with 2-, 4-, and 6-year mortality on follow-up; the CD4:8 ratio alone was found to be a proxy for the entire cluster (10) . The presence and general applicability of the CD4:8 ratio as a predictor of mortality among the oldest old have only been tested in a few longitudinal studies that reported nonconcordant numbers of individuals with an R < 1 and dissimilar results with regard to the association between CD4:8 ratio and mortality.
Recently, we investigated a new naïve T-cell-dominated signature at the other end of the CD4:8 ratio spectrum (defined as R > 5), which was associated with more impaired physical functioning in the oldest old compared with those with R < 1 (11) . Thus, the hypothesis that the accumulated late-differentiated cells are always detrimental to survival may not necessarily be true, at least not in the very elderly people. The idea that these cells may accumulate as a compensatory mechanism to maintain a necessary level of T-cell functionality, despite decreased per-cell activity (12) , supports the notion of extensive immune remodeling with age, due to pathogen and other exposures rather than to age per se (13) .
To test the presence and general applicability of the IRP in the oldest old, we investigated whether the previously identified CD4:8 ratio subsets (R < 1, 1 < R > 5, and R > 5) or changes in T-cell immunity in relation to CMV serostatus and gender were predictive for mortality over a follow-up period of 3 years in our representative population of Belgian very old people (mean age 86 years). Additionally, we sought to determine possible causal pathways by means of mediation analyses.
Materials and Methods

Study Population
Data were derived at the second data point (2010-2011) of the BELFRAIL study, a representative ongoing cohort study of individuals older than 80 years in Belgium. Eighteen months after baseline (T1), T-cell subsets were measured for a study population of 235 participants. This random subgroup with a mean age of 86.7 years was previously described in detail (11) . Follow-up questionnaires were collected after a mean period of 3.3 years (±0.10) years starting from T1 for each participant, with none lost to follow-up. All participants in the study gave informed consent, and the Biomedical Ethics Committee of the Medical School of the Université Catholique de Louvain of Brussels approved the study.
CD4:8 T-Cell Ratio and T-Cell Subsets
Peripheral blood mononuclear cells (PBMCs) were isolated and cryopreserved from 276 study participants. Thawed PBMCs were treated with human immunoglobulin, GAMUNEX (Bayer, Leverkusen, Germany), and ethidium monoazide (EMA; Invitrogen, Karlsruhe, Germany) to block Fc receptors and label nonviable cells and then stained indirectly with anti-CCR7 primary antibody (R&D Systems, Wiesbaden-Nordenstadt, Germany) and Pacific Orange-conjugated goat anti-mouse IgG (Invitrogen, Karlsruhe, Germany). After blocking with mouse serum (Chemicon/Millipore, Schwalbach, Germany), directly conjugated mAbs, CD3-Alexa Fluor 700, CD4-PerCP, CD8-allophycocyanin-H7, CD45-RA-V450, CD28-PE (BD Biosciences, Heidelberg, Germany), CD27-allophycocyanin (BioLegend, San Diego, CA), and CD57-FITC (Immunotools, Freiburg, Germany) were added. After 20 minutes of incubation on ice, cells were washed and analyzed immediately on an LSR II cytometer with FACSDiva software (BD Biosciences). Data were analyzed using FlowJo Software (Tree Star, Portland, OR). EMA-positive cells were excluded. T cells within the lymphocyte gate were characterized according to surface expression of CD45RA, CCR7, CD27, and CD28 based on a model suggested by Romero and colleagues (11, 14) . Flow cytometry staining and data analysis were performed on blinded samples. T-cell subsets were expressed as proportions and absolute T-cell numbers (count/μL; we calculated the CD4:8 ratio for 235 tested individuals and stratified them into three groups defined by R < 1, 1 < R < 5, and R > 5).
CMV Serostatus
CMV serostatus was determined for all individuals using recombinant CMV IgG immunoblotting (Mikrogen, Neuried, Germany) with six different proteins (IE1, p150, CM2, p65, gB1, and gB2). Based on band intensity, weak (+), strong (++), and very strong reactivity (+++) scores were defined, whereas marginally detectable bands were ignored. An individual was defined as CMV IgG-positive when reactivity was at least (+) for p150 or other antigens compared with a control, according to the manufacturer's protocol. Serostatus was confirmed by establishing a positive CMV IgG titer (>6 UA/ mL), measured on the ARCHITECT i4000SR (Abbott Diagnostics, Abbott Park, IL).
Comorbidity
Total comorbidity count for every individual was determined by summing up all coexistent cardiovascular and noncardiovascular diseases (Supplementary Table 1 ). The burden of comorbidity was then dichotomized to high (above the median) or low (below the median).
Statistical Analyses
Continuous data are presented as the mean + SD or median and interquartile range. Categorical data are presented as numbers and frequencies. Comparisons between different categories of participants were performed using the Student's t test or Wilcoxon rank sum test for continuous data, depending on the distribution, and the χ 2 tests or Fisher's exact test for categorical data; p less than .05 was considered to be statistically significant.
Complementary to the bivariate analysis, multivariable Cox proportional hazard models were used to estimate the adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for the association between the CD4:8 ratios or T-cell subsets (entered as continuous variables) and time until death. Models were corrected for the individual's age and high or low comorbidity burden. Cox proportional hazard plots are shown for the corrected models. Confounders were limited and models were consecutively built up to test model validity and avoid overcorrection. The proportional hazard assumption was met for all related analyses and no multicollinearity was detected. All analyses were stratified for gender. Multivariable logistic regression analysis was performed to estimate the odds ratio (OR) and 95% CI of the association between CMV and CD4:8 ratios.
Additionally, causal mediation analysis was performed to explore a possible causal pathway where CMV predominates the predictive capacity of the CD4:8 ratio for 3-year mortality. Mediation analysis is a model seeking to identify the mechanism that underlies an observed relationship transmitting the effect of an independent variable on dependent variables (here, survival). For the outcome variable survival, generalized linear regression models were used to test the effect of the mediator variables (ie, CD4:8 ratio). This allowed for splitting the total prediction effect into one pathway where the prediction is associated with the outcome by changes in CD4:8 ratio and the other pathway with directly observed changes. Average values of control and treated analyses are shown.
The statistical analyses were performed using STATA 11 (Statacorp, College Station, TX) and GraphPad prism 6 (GraphPad Software, San Diego, CA). Mediation analysis was performed using the causal mediation analysis package (15) for the computing environment R version 3.1.2 (R Foundation for Statistical Computing, Vienna, Austria).
Results
Correlates of Immunity in Survivors and Nonsurvivors: Effect of Sex
The total study population (mean age 86.7 ± 3.73 SD) consisted of 235 individuals of whom 158 were women (67.2%). Women were, at baseline, more frequently CMV seropositive than men (p = .014) and showed a trend toward higher comorbidity. During the mean follow-up period of 3.3 years (±0.10), 72 (30.6%) individuals of the total population died. The nonsurvivors were more frequently women (69.4%) and CMV seropositive (69.4%). Both the deceased women and men had a significantly higher age and number of comorbidities ( Table 1) . Analysis of the CD4:8 ratio showed that 17 individuals (7.2% of the study population) had a R < 1, 12 (70.6%) of whom were women, 141 (60% of the study population) had a 1 < R < 5, 96 of whom (68%) were women, and 77 (32.8%) had a R > 5, 50 of whom (64.9%) were women. The T-cell subset distribution in relation to CD4:8 ratio was previously described in detail (11) . Briefly, no statistically significant difference was observed across groups in terms of CD4 T cells but the group with R > 5 had a significant lower median CD8 T-cell content. Furthermore, a significantly higher proportion of naïve CD4 and CD8 T cells and a significantly lower proportion of effector CD4 and CD8 T cells were observed (Supplementary Table 2 ). No associations were found between survivors and nonsurvivors with respect to CD4:8 ratios, T-cell subsets, or CMV serostatus.
Highest Survival Rate in Women With an Inverted CD4:8 Ratio Table 2 shows HRs and 95% CI from Cox regression analyses examining the association between CD4:8 ratios or T-cell subsets and allcause mortality, adjusted for age and comorbidity and stratified for gender. In women, a HR of 1.63 (95% CI: 1.0, 2.64) was found with increasing CD4:8 ratios, but there were no significant survival associations in men (Figure 1) . No other significant differences in mortality were found for T-cell subset distribution (Table 2) or absolute numbers of T cells in these subsets (Supplementary Table 3 ). Other factors independently associated with a higher mortality rate in women were high comorbidity and high age.
Lower Mortality Rates for CMV-Seropositive Women
When correcting the above model for CMV serostatus, the hazard for all-cause mortality increased 1.53-fold (95% CI: 0.94-2.51) with every increment in the CD4:8 ratio from R < 1, to 1 < R < 5 and R > 5 among women (Table 3) . However, this tendency just failed to reach statistical significance (p = .088). Again, there were no significant differences in mortality rates at different CD4:8 ratios for men. Moreover, in women, CMV seropositivity was independently and negatively associated with all-cause mortality (HR 0.5, 95% CI: 0.27-0.94) (Figure 2 ).
CMV-Independent Mortality Prediction Capacity of CD4:8 Ratio Subsets
CMV serostatus was also strongly associated with the CD4:8 ratio. Multivariable logistic regression analysis showed an OR of 0.91 (95% CI: 0.86-0.97) for CMV seropositivity at every increment in the CD4:8 ratio (p = .004; results not shown). Therefore, a possible mediating role of the CD4:8 ratio in the relationship between CMV and mortality was explored by means of causal mediation analysis of the significant relationship in women. This revealed that 5.1% of the total mortality effect of CMV serostatus was mediated by the CD4:8 ratio groups (when varying the dependent variable from R < 1 to R > 5; Figure 3 ) (not significant).
Discussion
This study sought to identify elderly individuals with the highest survival over 3 years of follow-up, based on their CD4:8 ratio and with respect to their gender and CMV serostatus. We report a positive, rather than negative, relationship between the CD4:8 ratio and allcause mortality in women, when correcting for age and comorbidity, but no impact whatsoever in men. We also report an independent positive association between CMV infection and survival in women. CMV-negative women with a CD4:8 ratio above 5 showed the highest mortality rates over the follow-up period.
CD4:8 and Its Relation to Survival
In line with the OCTO/NONA studies, Huppert and coworkers showed that an inverted CD4:8 ratio predicted mortality in a UK sample of elderly people (6, 9, 16) . In contrast, no association of an inverted CD4:8 ratio with 3-year mortality was found in the Spanish OCTOBAIX study of 85-year olds and with 5-year mortality in the Women's Health and Aging Studies of women 65 years and older from Baltimore (17, 18) . The Newcastle 85+ study reported opposite relationships with memory/naïve CD8 + T-and B-cell ratios in a large population-based study of 85-year olds (19) . The Leiden 85+ study of individuals 88 years or older also reported an inverse relationship between the percentages of naive CD8 + T cells and survival, with accumulations of CMV-specific proinflammatory CD8 + memory T cells imbuing individuals with a survival advantage over 8-year follow-up (20) . In the present study, we could not confirm any of these previous findings. Instead, we unexpectedly observed the CD4:8 ratio to be positively associated with mortality in women but not in men at very high age.
Dissimilarities Between Study Cohorts of Very Old Individuals
The clinical impact of the CD4:8 ratio thus seems to differ across cohorts of very old populations and may depend on age at baseline, sex, genetic background, and environmental factors such as CMV infection, lifetime exposure to pathogens, other antigens, toxins, stressful life events, and other suspected but unidentified factors (11, 21, 22) . In this context, we note that although the BELFRAIL, OCTO, and NONA populations of very old individuals were quite similar with respect to their age distribution, they did differ importantly with regard to their life expectancy at birth. Thus, the BELFRAIL population had a life expectancy at birth of between 51
and 57 years with a nadir of 35 years in 1918, while for the OCTO population this was between 46 and 49 years and for NONA 50 to 53 years (http://www.gapminder.org). Also lower mortality rates were observed in the Belgian BELFRAIL (30% in 3.3 years) and Dutch Leiden 85+ study (16% in 2 years), compared with 26.5% in 2 years in the Swedish OCTO study (6, 20) . These differing life expectancies and mortality rates are likely to reflect different genetics, diet, lifestyle, access to medical facilities and exposure to epidemics, plagues, wars, pollution, and other environmental factors.
CMV and Its Relation to CD4:8 Ratio and Survival
Several studies have shown that CMV infection in elderly people is associated with an accumulation of late-stage differentiated CD8 + T cells which may lead in some individuals to an inverted CD4:8 ratio (5, 8, 10, 11) . In line with these findings, we showed that CMV seropositivity was inversely associated with the CD4:8 ratio but quite unexpectedly we also observed a survival advantage of CMVseropositive women over CMV-seronegative women at 3-year follow-up, but no effect, whatsoever, in men. Adding CMV serostatus to the model caused CD4:8 to become (marginally) insignificant. We therefore hypothesized that CMV's relationship with mortality might be mediated by its effect on the CD4:8 ratio (Figure 3 ). Mediation analysis, however, indicated that the relationship between mortality and CMV serostatus and the CD4:8 ratio in this population of very old people reflected distinct causal pathways. The apparent advantage of CMV seropositivity in women is unexpected, given the results of two recent large population-based studies showing an independent but positive relationship between CMV seropositivity and all-cause mortality (23, 24) . We believe these apparently contradictory findings may be the result of a survival effect because one of these studies concerned a younger population compared with the BELFRAIL population, consisting of individuals aged 40-79 years at baseline (23) . In the other study, CMV's impact on mortality was mainly observed in individuals aged 55-75 years, whereas CMV imposed little increased risk in the most elderly individuals, aged 75-90 years (24) . Also, in the baseline BELFRAIL population, no relation between CMV serostatus and 5-year mortality was observed (25) . The fact that in the subgroup of the BELFRAIL population surviving 18 months after baseline-the participants of this study-CMV seropositivity Note: CI = confidence interval; CM = central memory; E = effector; EM = effector memory; HR = hazard ratio; N = Naïve. The hazard of all-cause mortality increases with every increment in the CD4:8 ratio from R < 1, to 1 < R < 5 and R > 5. Predicted survival curves from Cox proportional hazard models for R < 1, 1 < R < 5, and R > 5 adjusted for morbidity burden and age. Upper and lower graphs show the Cox regression plots for women and men, respectively.
became advantageous-at least in women-supports the idea of a survival effect, that is, by selection of individuals less susceptible to any adverse effects of CMV (25, 26) .
Highest Mortality in Very Old Individuals With a R ≥ 5
In contrast to the better survival of the R < 1 individuals, the highest mortality rates in the present study were observed among those with a CD4:8 ratio above 5. We previously showed the latter to be characterized by a low CD8 + T-cell count and a naïve-dominated phenotype, irrespective of CMV infection (11) . The source and nature of these accumulating naïve T cells in some of the very old participants remain unclear. New evidence points in the direction of peripheral expansion of naïve-like T cells possibly having somewhat different characteristics to the true naïve T cells (27) (28) (29) . We interpreted these results to imply that the high burden of repeated infectious diseases could tip the balance whereby at late ages, the naïve-dominated phenotype, previously necessary to defend against new pathogens, now becomes less important in the more protected mostly indoor environment now experienced by free-living elderly individuals. Reciprocally, the presence of more memory cells for persistent pathogens, gains in importance under these circumstances, Mediation analysis splitting up the total predicted effect or average direct effect (ADE) of CMV serostatus on mortality in a direct effect (ADE) and an indirect effect mediated or average causal mediation effect (ACME) by CD4:8 ratio (ACME). The ACME comprised 5.1% of the total predicted effect of CMV serostatus on mortality and was not statistically significant. Note: CI = confidence interval; CM = central memory; E = effector; EM = effector memory; HR = hazard ratio; N = Naïve.
as illustrated in the Leiden 85+ study (13) . In this respect, in the NONA study, Hadrup and colleagues showed an inverse association between the mortality rate at follow-up and the number of CMVspecific clonal expansions in CMV-seropositive nonagenarians (30) , suggesting that containment of CMV infection is the most crucial factor for survival at very old age. Ferrando-Martinez and colleagues, when studying the pp65-specific CD8 T-cell response in a cohort of CMV-seropositive individuals aged 50 and older, observed a less polyfunctional phenotype in nonsurvivors as compared with survivors (31) . Furthermore, results of some more recent studies suggest that CMV may induce cross-protection against other unrelated infectious agents by maintaining the immune system in a state of "high alert" (19, 32, 33) . This suggests that the immune phenotypes linked to survival in very late life are probably different from those in less than oldest-old adults.
Sex Differences
What might account for the marked differences between men and women noted here? Besides the higher disease burden, CMV prevalence and longevity in women, differences between sexes in terms of T-cell immunity have long been known (3). Hormonal and genetic effects, but also possible modulatory roles of the X chromosome, have been proposed (4) .
Conclusions
The strength of this research is the longitudinal approach of a large population-based sample including those living in the community and institutions and frail elderly people. To test mortality prediction capacity of immune cell phenotypes, we chose a feasible 3-year follow-up period at this high age (30% deaths at follow-up). More detailed immune characteristics (inflammation levels, B cells, CMV IgG and IgM titers, CMV-specific T cells) will be assessed to obtain a fuller picture of the CMV status in individual participants. A limitation is the low number of men included, in particular in the R < 1 group.
In this large population-based study of persons aged around 86 years at baseline, we demonstrated that very elderly CMVseronegative women with a CD4:8 ratio above 5 experienced the highest mortality rates, independent of age and comorbidity. Our findings confirm the importance of the frequently neglected role of sex as a variable, because all associations determined here were seen solely in women. CMV serostatus and CD4:8 ratio seem to be factors in distinct pathways mediating survival at very old age. These results emphasize the context-dependent nature of immune biomarkers associating with mortality in different human populations and argue against current generalizations concerning human immunosenescence. They indicate the necessity for detailed comparisons of different populations, even those that appear quite similar at first glance.
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Supplementary data are available at The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences online.
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